Low density lipoprotein cholesterol (H-LDL) and remnant non-HDL cholesterol: any reason to change the order when assessing cardiovascular risk?

Abstract

The paper reviews the relevance of various types of cholesterol as factors of cardiovascular risks. According to recent recommendations, apart from the routinely evaluated low-density lipoprotein cholesterol (LDL-H), clinicians now look at non-HDL (high-density lipoprotein) cholesterol. The paper questions, whether there is enough clinical and scientific evidence to change priorities in the lipid assessment of cardiovascular risk: measurement and monitoring of non-HDL cholesterol vs. routine lipid markers - LDL cholesterol and plasma HDL cholesterol.

Keywords

• cholesterol
• low-density lipoproteins
• high density lipoproteins
• non-hdl cholesterol
• lipid correcting therapy
• cardiovascular risk factors
• холестерин
• липопротеины низкой плотности
• холестерин не лвп
• липидкоррегирующая терапия
• факторы сердечно-сосудистого риска